 |
emixustat |
|---|---|
| Trade Name | |
| Orphan Indication | Stargardt Disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-04 00:00:00 |
| Sponsor | Acucela Inc.;1301 2nd Avenue, Suite 4200;Seattle, Washington, 98101 |
| |
emixustat |
|---|---|
| Trade Name | |
| Orphan Indication | Stargardt Disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-04 00:00:00 |
| Sponsor | Acucela Inc.;1301 2nd Avenue, Suite 4200;Seattle, Washington, 98101 |